New breast scanner could spot cancer more clearly
NCT ID NCT05659797
First seen Feb 28, 2026 · Last updated May 21, 2026 · Updated 12 times
Summary
This early-phase study tests a new imaging device that combines a special PET scan with 3D mammography to get a clearer picture of estrogen-receptor-positive breast cancer. About 20 adults with newly diagnosed breast cancer will receive an injection of a radioactive tracer that binds to estrogen receptors, then undergo imaging. The goal is to see if this method can better measure the size and extent of the tumor compared to standard imaging. This is an observational study only; results will not guide treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19130, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.